Similar articles

• Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.

  Mustafa AS. Mustafa AS. Int J Lepr Other Mycobact Dis. 1996 Sep;64(3):257-67. Int J Lepr Other Mycobact Dis. 1996. PMID: 8862259
• A strategy to improve the efficacy of vaccination against tuberculosis and leprosy.

  Bretscher PA. Bretscher PA. Immunol Today. 1992 Sep;13(9):342-5. doi: 10.1016/0167-5699(92)90168-7. Immunol Today. 1992. PMID: 1466750 Review.
• Characteristics of human T-cell clones from BCG and killed M. leprae vaccinated subjects and tuberculosis patients. Recognition of recombinant mycobacterial antigens.

  Mustafa AS, Oftung F, Gill HK, Natvig I. Mustafa AS, et al. Lepr Rev. 1986 Dec;57 Suppl 2:123-30. Lepr Rev. 1986. PMID: 3106732 No abstract available.
• Elimination of Mycobacterium leprae subsequent to local in vivo activation of macrophages in lepromatous leprosy by other mycobacteria.

  Convit J, Pinardi ME, Rodríguez Ochoa G, Ulrich M, Avila JL, Goihman M. Convit J, et al. Clin Exp Immunol. 1974 Jun;17(2):261-5. Clin Exp Immunol. 1974. PMID: 4619359 Free PMC article.
• The significance of proteins actively secreted by Mycobacterium tuberculosis in relation to immunity and complications of mycobacterial diseases.

  Harboe M. Harboe M. Int J Lepr Other Mycobact Dis. 1992 Sep;60(3):470-6. Int J Lepr Other Mycobact Dis. 1992. PMID: 1474286 Review. No abstract available.